Home Categories 9-cis-Retinoic Acid
A2498012

9-cis-Retinoic Acid , ≥98%(HPLC) , 5300-03-8

Synonym(s):
9-cis-Tretinoin;Alitretinoin

CAS NO.:5300-03-8

Empirical Formula: C20H28O2

Molecular Weight: 300.44

MDL number: MFCD00270072

EINECS: 1533716-785-6

Pack Size Price Stock Quantity
1MG RMB631.20 In Stock
5MG RMB2799.20 In Stock
10mg RMB4479.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 189-191°C
Boiling point: 462.8±14.0 °C(Predicted)
Density  1.011±0.06 g/cm3(Predicted)
RTECS  VH6450000
storage temp.  -20°C
solubility  Acetonitrile (Very Slightly), Chloroform (Slightly), DMSO (Slightly), Ethanol (
pka 4.73±0.33(Predicted)
form  Light yellow to orange crystalline powder.
color  Pale Yellow to Yellow
biological source natural
Water Solubility  Soluble in chloroform (50 mg/ml), DMSO (~25 mg/ml), ethanol (25 mg/ml), and acetone (25 mg/ml). Insoluble in water.
Sensitive  Moisture & Light Sensitive
Stability: Store Dry in Freezer at -20°C for up to 1 year; in Solution at -20°C for up to 3 Months.
InChI InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+
InChIKey SHGAZHPCJJPHSC-ZVCIMWCZSA-N
SMILES C(O)(=O)/C=C(/C=C/C=C(\C=C\C1C(C)(C)CCCC=1C)/C)\C
CAS DataBase Reference 5300-03-8(CAS DataBase Reference)

Description and Uses

Alitretinoin was introduced in the US for the topical treatment of cutaneous lesions in patients with Kaposi's sarcoma (KS), the most frequent malignancy observed in AIDS patients. It is a derivative of 9-cis-retinoic acid (9- cis-RA) identified as an endogenous hormone in mammalian tissues. Alitretinoin binds to all isoforms of the intracellular retinoid X (RXR) and retinoid A (RAR) receptors thus inducing cell differentiation, increasing cell apoptosis and inhibiting cellular proliferation in experimental models of human cancer. In an international phase III trial in patients with KS, 42% of 82 patients treated with 0.1% gel formulation experienced complete or partial responses cf 7% for controls. Alitretinoin is the first topical therapy for KS and is expected to be a new option to its traditional management.

9-cis-Retinoic acid is a vitamin A analog that inhibits cell proliferation and induces cell differentiation. 9-cis-Retinoic acid is an inhibitor of Cox-2 and an activator of RAR α, RAR β, RAR γ and RXR.

Safety

Symbol(GHS) 
GHS07,GHS08
Signal word  Danger
Hazard statements  H315-H319-H335-H360
Precautionary statements  P201-P302+P352-P305+P351+P338-P308+P313
Hazard Codes  T
Risk Statements  61-36/37/38
Safety Statements  53-26-36/37/39-45
WGK Germany  3
HS Code  29162090
Hazardous Substances Data 5300-03-8(Hazardous Substances Data)

RELATED PRODUCTS